Leap Therapeutics, Inc.
11 clinical trials · Sponsor
◉ Watch Leap Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of DKN-01 in Colorectal Cancer (NCT05480306) | Leap Therapeutics, Inc. | 2022-08-30 |
| A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer (NCT04363801) | Leap Therapeutics, Inc. | 2020-07-29 |
| A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors (NCT03861403) | Leap Therapeutics, Inc. | 2019-05-20 |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma (NCT03395080) | Leap Therapeutics, Inc. | 2018-03-05 |
Track Leap Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.